{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:30Z","timestamp":1793978910187,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0528800"],"award-info":[{"award-number":["2024ZD0528800"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","award":["SKLRD-OP-202506"],"award-info":[{"award-number":["SKLRD-OP-202506"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502685"],"award-info":[{"award-number":["82502685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574233"],"award-info":[{"award-number":["82574233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFE0214800"],"award-info":[{"award-number":["2024YFE0214800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119208","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:32Z","timestamp":1786115072000},"page":"119208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of tetrahydroquinazoline compounds as Fusion protein inhibitors for the treatment of respiratory syncytial virus"],"prefix":"10.1016","volume":"319","author":[{"given":"Haibin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changtai","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Kashif","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiubao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-1811","authenticated-orcid":false,"given":"Yingjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119208_bib1","first-page":"56","article-title":"Respiratory syncytial virus: a review of current basic and clinical knowledge","volume":"2024","author":"Alsaleh","year":"2024","journal-title":"Qatar Med. J."},{"key":"10.1016\/j.ejmech.2026.119208_bib2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119208_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/ciy991","article-title":"Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults","volume":"69","author":"Ackerson","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119208_bib4","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-66-10-2111","article-title":"Two distinct subtypes of human respiratory syncytial virus","volume":"66","author":"Mufson","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejmech.2026.119208_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119208_bib6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119208_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.46010","article-title":"Hospitalization following outpatient diagnosis of respiratory syncytial virus in adults","volume":"7","author":"Landi","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ejmech.2026.119208_bib8","first-page":"1223","article-title":"Expert consensus on the passive immunization prevention of infant respiratory syncytial virus infection in China","volume":"25","author":"Xu","year":"2024","journal-title":"Chin. Prev. Med. Assoc."},{"key":"10.1016\/j.ejmech.2026.119208_bib9","first-page":"1","article-title":"The recent landscape of RSV vaccine research","volume":"13","author":"Kelleher","year":"2025","journal-title":"Ther. Adv. Vaccines. Immunother."},{"key":"10.1016\/j.ejmech.2026.119208_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/v18010036","article-title":"Crucial obstacles and strategies for human RSV pediatric vaccine development","volume":"18","author":"Ling","year":"2025","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119208_bib11","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1080\/21645515.2017.1337614","article-title":"Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection","volume":"13","author":"Resch","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119208_bib12","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1542\/peds.2006-2223","article-title":"Diagnosis and management of bronchiolitis","volume":"118","author":"Lieberthal","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejmech.2026.119208_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000181.pub3","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","volume":"1","author":"Ventre","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2026.119208_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.ejmech.2026.119208_bib15","first-page":"3","article-title":"Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2026.119208_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01884-19","article-title":"A randomized, placebo-controlled, respiratory syncytial virus human challenge study of the antiviral efficacy, safety, and pharmacokinetics of RV521, an inhibitor of the RSV-F protein","volume":"64","author":"DeVincenzo","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119208_bib17","article-title":"Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: a phase 2 proof-of-concept trial, influenza. Other. Respi","volume":"17","author":"Huang","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119208_bib18","doi-asserted-by":"crossref","first-page":"11543","DOI":"10.1021\/acs.jmedchem.4c00630","article-title":"Recent progress toward the discovery of small molecules as novel anti-respiratory syncytial virus agents","volume":"67","author":"Felicetti","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib19","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.apsb.2025.02.015","article-title":"Advances in development of antiviral strategies against respiratory syncytial virus","volume":"15","author":"Yang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119208_bib20","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/JVI.77.9.5054-5064.2003","article-title":"Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 viaspecific interactions with F protein","volume":"77","author":"Douglas","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119208_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12503","article-title":"The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin","volume":"11","author":"Kim","year":"2017","journal-title":"Influenza. Other. Respir. Viruses."},{"key":"10.1016\/j.ejmech.2026.119208_bib22","first-page":"49","article-title":"Anno 2021: which antivirals for the coming decade?","volume":"57","author":"Groaz","year":"2021","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib23","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/cid\/ciz1169","article-title":"Clinical development of respiratory syncytial virus antivirals-what we can learn from oseltamivir","volume":"71","author":"L\u00f6wensteyn","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119208_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/infdis\/jiy227","article-title":"Antiviral activity of oral JNJ-53718678 in healthy adult volunteers challenged with respiratory syncytial virus: a placebo-controlled study","volume":"218","author":"Stevens","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119208_bib25","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1021\/acs.jmedchem.1c00987","article-title":"Structure-based design and discovery of pyridyl-bearing fused bicyclic HIV-1 inhibitors: synthesis, biological characterization, and molecular modeling studies","volume":"64","author":"Huang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113218","article-title":"FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: synthesis and clinical application","volume":"214","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib27","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/acs.jcim.1c00075","article-title":"MolGpka: a web server for small molecule pKa prediction using a graph-convolutional neural network","volume":"61","author":"Pan","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119208_bib28","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/acs.jmedchem.9b00654","article-title":"Discovery of ziresovir as a potent, selective, and orally bioavailable respiratory syncytial virus fusion protein inhibitor","volume":"62","author":"Zheng","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115802","article-title":"Applications of oxetanes in drug discovery and medicinal chemistry","volume":"261","author":"Huang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib30","doi-asserted-by":"crossref","first-page":"12697","DOI":"10.1021\/acs.jmedchem.3c01101","article-title":"Oxetanes in drug discovery campaigns","volume":"66","author":"Rojas","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib31","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1002\/anie.200602343","article-title":"Oxetanes as promising modules in drug discovery","volume":"45","author":"Wuitschik","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119208_bib32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/acs.jmedchem.7b01375","volume":"61","author":"Kung","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Christopher","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.119208_bib34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/qsar.200330868","article-title":"A general model for prediction of Caco-2 cell permeability, QSAR","volume":"23","author":"Nordqvist","year":"2004","journal-title":"Comb. Sci."},{"key":"10.1016\/j.ejmech.2026.119208_bib35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ijpharm.2015.09.035","article-title":"Evaluation of the appropriate time range for estimating the apparent permeability coefficient (Papp) in a transcellular transport study","volume":"495","author":"Ozeki","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2026.119208_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/minf.201000159","article-title":"Development and comparison of hERG blocker classifiers: assessment on different datasets yields markedly different results","volume":"30","author":"Marchese Robinson","year":"2011","journal-title":"Mol. Inf."},{"key":"10.1016\/j.ejmech.2026.119208_bib37","doi-asserted-by":"crossref","first-page":"e03511","DOI":"10.1128\/mbio.03511-21","article-title":"The human nose organoid respiratory virus model: an Ex vivo human challenge model to study respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis and evaluate therapeutics","volume":"13","author":"Rajan","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119208_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013864","article-title":"Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus","volume":"22","author":"Yan","year":"2026","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119208_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/ijms24010326","article-title":"The role of pulmonary surfactant phospholipids in fibrotic lung diseases","volume":"24","author":"Tlatelpa-Romero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119208_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.119208_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein. Sci."},{"key":"10.1016\/j.ejmech.2026.119208_bib42","doi-asserted-by":"crossref","first-page":"25939","DOI":"10.1021\/acs.jmedchem.5c01837","article-title":"Design, synthesis, and biological evaluation of highly potent boronic acid (Boronate Ester)-Bearing heteroaryldihydropyrimidine derivatives as HBV capsid assembly","volume":"68","author":"Jin","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2227777","article-title":"Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77modulators with potent antitumor activity against hepatocellular carcinoma","volume":"38","author":"He","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119208_bib44","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/acsmedchemlett.9b00438","article-title":"Design and synthesis of Tetrazole- and Pyridine- containing itraconazole analogs as potent angiogenetic inhibitors","volume":"11","author":"Li","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119208_bib45","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:06:31Z","timestamp":1793977591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"alternative-id":["S0223523426006537"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119208","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of tetrahydroquinazoline compounds as Fusion protein inhibitors for the treatment of respiratory syncytial virus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119208"}}